Status | Study |
Completed |
Study Name: The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT Condition: Nasopharyngeal Neoplasms Date: 2013-02-21 Interventions: Drug: Cisplatin induction: Cis |
Recruiting |
Study Name: Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2012-11-22 Interventions: Drug: ABX + DDP ABX 260 mg/m2 |
Active, not recruiting |
Study Name: Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2012-01-31 Interventions: Drug: gemcitabine and cisplatin |
Completed |
Study Name: Environmental and Genetic Determinants of NPC Condition: Nasopharyngeal Neoplasms Herpesvirus 4, Human Date: 2010-12-08 |
Completed |
Study Name: Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Condition: Nasopharyngeal Neoplasms Date: 2008-09-04 Interventions: Drug: Sorafenib plus Cisplatin and 5-fluorouracil Sorafeni |
Completed |
Study Name: Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy Condition: Nasopharyngeal Neoplasms Date: 2008-02-25 Interventions: Drug: Pemetrexed (Alimta) 500 mg/m2 in Cycle 1, every 3 weeks, with folic acid and vitamin B12 supplemen |
Completed |
Study Name: Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer Condition: Nasopharyngeal Neoplasms Date: 2007-12-18 Interventions: Procedure: Conventional Radiotherapy Proce |
Completed |
Study Name: Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents Condition: Nasopharyngeal Neoplasms Carcinoma Date: 2007-11-29 Interventions: Drug: docetaxel |
Completed |
Study Name: Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2007-02-16 Interventions: Drug: Gemcitabine 1000mg/m |
Completed |
Study Name: Taxotere + Cisplatin in Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2007-02-16 Interventions: Drug: Docetaxel 75 mg/m² |